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Abstract 
Purpose and Background/Significance:  Cardiovascular disease (CVD) and type 2 diabetes 
mellitus (T2DM) are prevalent comorbid health conditions in adults, affecting roughly 65% of 
U.S. adult population, and are among the leading causes of premature disability and mortality. 
An underlying inflammatory mechanism is hypothesized in the development and progression of 
CVD. Poor T2DM control, depression, and stress are inflammatory processes that are associated 
with an increased risk of CVD events, including hypertension, myocardial infarction, stroke, and 
kidney disease.  The purpose of this thesis was to test a model of the relationships between 
T2DM control, depression, and stress measures as predictors of CVD risk factors and events in a 
sample of adults (N=45) with T2DM and depressive symptoms. It was hypothesized that, after 
controlling for socio-demographic characteristics and clinical characteristics, there would be: (a) 
a positive association between biological and self-report stress measures with self-reported 
cardiovascular events and risk factors, and; (b) A1c and smoking status would be positively 
related to biological and self-report distress measures and to self-reported CVD risk 
factors/events.   
 
Methods: A secondary analysis was done using baseline (pre-intervention) data from a 
randomized trial of a 12-week patient-centered decision support intervention (n=45) to improve 
patient decision-making about managing depressive symptoms in context of T2DM. 
Standardized measures included glycemic control (A1c), depression (Patient Health 
Questionnaire-9), self-reported and biomarker stress measures (Diabetes Distress Scale; salivary 
α-amylase), and a dichotomized self-report measure of four CVD risk factors and events (0 = no 
risk factors/events; 1 = at least one risk factor/event).  Regression analysis was used to model 
relationships of glycemic control, depression, and, in predicting CVD risk factors/ events 
(hypertension, heart disease, kidney disease, stroke), after initially controlling for socio-
demographic characteristics (age, gender, race) and smoking status. 
  
Results: Unadjusted bivariate relationships were statistically significant for PHQ-9 and DDS (r 
= .550, p < .05), DDS and A1c (r = .314, p < .05), and smoking status and A1c (r = .299, p < 05).  
A logistic regression analysis revealed three statistically significant and positive predictors of 
CVD risk factors events (all p < .05): PHQ-9, DDS, and smoking status.  In the first regression 
model, salivary α-amylase was used as a continuous variable and trended towards significance (p 
= .082), and when used as a binary predictor, approached statistical significance (p = .051) in 
predicting CVD risk factors/events.  
 
Conclusion: This study contributes to knowledge about relationships between potentially 
modifiable psychological factors (depression, stress), risky health behaviors (smoking), and 
glycemic control in predicting CVD risk factors/events. This knowledge can inform improved 
healthcare interventions to reduce the morbidity and mortality associated with cardiovascular 
disease and diabetes. 
Introduction 
Diabetes is the seventh leading cause of death in the United States. Cardiovascular events 
including myocardial infarction and stroke account for 70% of deaths in patients with type 2 
diabetes mellitus (T2DM) (Zhang et al, 2012).  Diabetes is a chronic disease that destroys the 
arterial vasculature in both small and large capillaries. This disease process, if inadequately 
managed, can result in clinically significant cardiovascular disease (CVD), and heightened risk 
for adverse cardiovascular events.  The interrelationships between diabetes and CVD are a 
priority area for additional research in order to reduce premature morbidity and mortality 
associated with diabetes and adverse cardiovascular events (Center for Disease Control and 
Prevention, 2011). 
There are multiple types of diabetes syndromes, with diabetes mellitus type 2 comprising the 
majority of diagnosed diabetes. Type 1 Diabetes (T1DM) is marked by a lack of insulin-
secreting beta cells in the pancreas. Without sufficient insulin, there is a resultant buildup of 
glucose in the vasculature, and exogenous insulin is required.  T1DM is generally diagnosed 
relatively early in life and is understood as an autoimmune disorder.  By contrast with T1DM, 
type 2 diabetes (T2DM) makes up approximately 95% of cases.  In T2DM, cells become 
resistant to insulin and are unable to store glucose and glycogen. An underlying pro-
inflammatory mechanism is hypothesized to be the link between hyperglycemia and cell damage. 
The result of insulin resistance is hyperglycemia, which has detrimental effects on the vascular 
system, resulting in significantly higher risk of adverse cardiovascular disease (CVD) events 
such as myocardial infarction, kidney dysfunction, stroke, and peripheral vascular disease  
A number of behavioral lifestyle factors can increase the likelihood of developing T2DM, 
including a sedentary lifestyle and an unhealthy diet.  T2DM is often accompanied by other CVD 
risk factors, such as elevated LDL cholesterol, hypertension, hyperglycemia, elevated BMI, and 
other psychosocial issues such as stress and depression.  These CVD risk factors are targets of 
behavioral lifestyle change interventions to prevent development or progression of T2DM and to 
reduce risk of CVD events.  These types of interrelationships between diabetes and CVD are a 
priority area for additional research within a goal to reduce premature morbidity and mortality 
associated with diabetes and adverse cardiovascular events (Center for Disease Control and 
Prevention, 2011). The overall goal of this thesis is to contribute to theoretical knowledge in this 
area by using an existing dataset to test a model of relationships between diabetes control and 
psychological distress measures (stress, diabetes-related distress, and depression) in accounting 
for CVD risk factors and events.   
Review of Literature 
Hyperglycemia and Cardiovascular Disease 
Long-standing hyperglycemia accelerates the rate of atherosclerosis and is related to increased 
incidence of cardiovascular events.  A recent meta-analysis that examined the relationship 
between A1c and cardiovascular- related mortality in patients with T2DM found that for every 
1% increase in A1c there was a 25% increase in CVD mortality (Zhang et al, 2012). 
Microvascular disease involves smaller arterial pathways, such as in the eyes, kidneys, and 
peripheral nerves, while macrovascular disease involves larger arteries.  Examples of 
macrovascular disease include cardiovascular disease, hypertension and stroke.  The relationship 
between glucose and microvascular disease has been shown to be very strong, but it is less clear 
how strong the relationship is to macrovascular disease (Selvin et al, 2004).  The Kumamoto 
Study and The Diabetes Control and Complications Trial research group have both shown 
conclusively that improved glycemic control decreases the incidence of microvascular disease 
and neuropathic problems. (DCCT, 1993, Okhubo et al, 1995).   Cardiovascular outcomes were 
then examined in relation to improved glycemic control but did not show as large of a correlation 
as with microvascular disease. The relationship between glycemic control and CVD, the leading 
cause of death for those with diabetes, is less clear.  The Diabetes Control and Complications 
trial saw a trend towards a positive correlation between improved glycemic control and 
decreased incidence of CVD and follow-up 9 years later did show a significant reduction in the 
risk for cardiovascular related death.  Three other large trials (ACCORD, ADVANCE, and 
VADT) found no reduction of CVD with increased glycemic control (Skyler, et al, 2009).  An 
extension of the VADT study found that if patients had less severe atherosclerosis at baseline, 
intensive glycemic control could significantly reduce their chances of cardiovascular events 
(Reaven, et al, 2009). More long-term follow up studies may provide more information on the 
relationship between glycemic control and macrovascular disease. 
Stress, Depression and Cardiovascular Disease  
A substantial relationship exists between psychological stress, depression and cardiovascular 
health. Clinically significant stress can contribute to adverse cardiovascular events.  For 
example, stress causes an increase in our heart rate and blood pressure which can cause 
atherosclerotic plaques to dislodge.  People with diabetes often experience complex ongoing 
psychosocial stressors, and relatively less is known about the impact these stressors have on 
cardiovascular health (Dimsdale, 2008).  Salivary α-amylase, an enzyme in the saliva, increases 
in response to physical or psychological stress and has been used as a stress biomarker in 
research on cardiovascular physiology (Granger et al, 2007).  Psychosocial stress is associated 
with a higher likelihood of smoking, hypertension and sedentary lifestyle, all of which are risk 
factors for T2DM (Gonzalez et al, 2007).  Depression, one of the major causes of disability and 
disease burden worldwide, is also a risk factor for development of heart disease.  A bidirectional 
association between depression and cardiovascular disease has been shown to exist.  Several 
studies show that individuals diagnosed with depression have higher mortality, especially 
cardiovascular related mortality (Bivanco-Lima et al, 2013).Those who are diagnosed with 
cardiovascular disease often also have an increased incidence of depression (Hemingway & 
Marmont, 1999). This correlation can be explained by a number of factors including higher 
vulnerability and decreased access to healthcare (Bivanco-Lima et al, 2013).  Another recent 
study has shown that although depression often accompanies CVD, and depression can best be 
seen as a “variable risk marker.”  However, there has been no evidence that shows that treating 
depression alters CVD outcomes (Meijer, Zuidersma, & de Jonge, 2013). 
Stress and Glycemic Control 
Individuals with T2DM have the added stress of managing their diet, exercise, and medications 
on a daily basis. Diabetes self-management needs can be complex and require substantial, highly 
challenging changes in lifestyle.  For example, people with diabetes often must regularly check 
their blood glucose, make significant changes in physical activity and diet, and administer 
medications, sometimes including insulin injections or use of other insulin administration 
devices. Added stress can decrease confidence in self-management abilities and worsen 
hyperglycemia. Stress can be generalized, reflecting general psychosocial stressors, or more 
specific to living with and managing diabetes on a daily basis.  Regardless of the specific sources 
of stress, there is evidence that interventions to reduce stress can help to improve chronic 
hyperglycemia (Surwit et al, 2002). However, additional research is needed to examine the 
relationships between specific types of stress and glycemic control. 
Depression, Diabetes-related Distress, and Diabetes Self-Management 
Depression has been found in a variety of studies to be associated with poor metabolic control 
(Gois et al, 2012).  The mechanisms for this relationship are complex, and include issues such as 
reduced treatment adherence and impaired self-management of diabetes.  People with diabetes 
are more likely to have depression when compared to the rest of the population (Egede, Zheng & 
Simpson, 2002).  Even mild depressive symptoms are associated with greater likelihood of 
suboptimal self-care behaviors, including decreased adherence to diet, exercise and medication 
regimens (Gonzalez et al, 2007).  Compared to people without diabetes and/or depression, people 
who have both diabetes and depression have increased functional impairment, spend more days 
in the hospital, and miss more days of work (Pouwer et al, 2003, Egede et al, 2004), have poorer 
glycemic control (Lustman et al, 2000), incur higher health care costs (Egede, Zheng, Simpson, 
2002), and have a higher risk of death and sickness (Katon et al, 2005).  The impact of 
depression is related to but conceptually distinct from stress and diabetes-related distress.  
Diabetes-related distress has been found to be more predictive of behavioral and biological 
outcomes compared to depressive symptoms (Fisher et al, 2010).  The relationships between 
depression, diabetes-related distress, and diabetes self-management are important areas for 
further research in relation to health outcomes.   
Diabetes-Related Distress and Hyperglycemia 
A1c is a biomarker that reflects extent of blood glucose control over a 3-month period and is a 
useful test to measure adequacy of T2DM management. A1c is now being used as a screening 
measure for disease prevention and health promotion.  A strong and positive relationship has 
been found between diabetes-related distress and A1c (Fisher et al, 2010).  However, research 
has shown that when interventions were implemented to improve depression among adults with 
diabetes, no subsequent decreases in A1c were noted (Katon et al, 2005).  Thus, the study of 
diabetes-related distress is promising in regard to potential for improving glycemic control.  For 
example, interventions research could be conducted to target sources of diabetes-related distress 
and to evaluate intervention effectiveness in relation to A1c improvements over time. Refining 
existing interventions to improve T2DM control is important to decrease the risk for CVD.  
Summary and Purpose 
After an extensive literature review, no research studies were located that specifically examined 
diabetes-related distress, glycemic control, stress, and depressive symptoms in relation to self-
reported CVD risk factors and events.  Many studies have explored linkages between two or 
three of the variables, but not all in conjunction.  Therefore, the purpose of this thesis is to use an 
existing dataset to test a model of relationships between longer-term diabetes control (A1c), 
stress (salivary α-amylase), diabetes-related distress (Diabetes Distress Scale; DDS) and 
depressive symptoms (Patient Health Questionnaire-9; PHQ-9) in predicting CVD risk factors/ 
events (hypertension, heart disease, kidney disease, stroke), after initially controlling for socio-
demographic characteristics (age, gender, race) and smoking status. 
Theoretical Model 
The theoretical model that guided this research is presented in Figure 1.  The model shows the 
hypothesized directional relationships between sociodemographic and clinical characteristics, 
biological and self-report distress measures, stress, and cardiovascular risk factors/events.   
Hypotheses 
1. After controlling for sociodemographic and clinical characteristics, each biological and 
self-report measures of distress (salivary α-amylase, PHQ-9, and DDS) will be positively 
related to self-reported CVD risk factors/events.   
2. A1c and smoking status will be positively related to biological and self-report distress 
measures and to self-reported cardiovascular risk factors/events.   
Methods 
This correlational descriptive study was a secondary analysis of a randomized pilot intervention 
study done with 45 adults with T2DM and depressive symptoms to test a novel decision support 
intervention (DSI) to improve decision-making about managing depressive symptoms. This 
thesis analysis used the baseline (pre-intervention) data to test the hypothesized model. 
Participants 
A socio-demographically diverse sample with multiple chronic co-morbidities, significant 
psychosocial stressors and significant health care barriers was used in the primary study.  
Participants were recruited from multiple sites including OSU Primary Care Research Network 
sites Advertisements, postings in local community centers and libraries, OSU diabetes clinic and 
Central Ohio Diabetes Association (CODA) advertisements, on site recruitment at community 
health fairs and diabetes health fairs, study invitations sent via the NIH CTSA-sponsored 
ResearchMatch health volunteer database, and advertisements in local print media.  Once 
participants were recruited and screened they were randomly assigned into one of two study 
groups (experimental – DSI + Usual Care, or control – Usual Care) based on a stratified 
(depressive symptom severity x gender) randomized block design.  Participants met the 
following inclusion/exclusion criteria: 
Inclusion and Exclusion Criteria 
Inclusion criteria included mild to moderate depression symptoms assessed with PHQ-9 
depression scale, access to telephone and transportation, and ability to complete required forms. 
Exclusion criteria included severe levels of psychological and physical distress, age, substance 
abuse disorders, history of psychiatric hospitalizations, history of suicidality, and severe physical 
pain or terminal illness. 
External and Internal Validity 
The primary study used a sample representative of the population of adults who have T2DM and 
mild to moderate depressive symptoms and complex psychosocial stressors in central Ohio, 
potentially making the results of the study potentially generalizable to a comparable population 
of adults.  The randomized study design helped to minimize threats to internal validity in the 
primary study. 
Measures 
All measures used have been previously used in similar research with adults with T2DM and 
depression and have known psychometrics.  An overview of the measures used in this secondary 
analysis is included below. 
Health Conditions Questionnaire 
In the primary study, patients were asked to identify any current health conditions from a list of 
16 conditions besides T2DM.  A sum score was calculated for the total number of health 
conditions. For the purposes of this secondary analysis, four health conditions (heart 
disease/trouble, kidney disease/trouble, hypertension, stroke), and one additional behavioral 
variable (smoking status) were used in the analysis. 
Salivary α-amylase 
Salivary α-amylase is a point-of-care test used to measure sympathetic nervous system (SNS) 
activity or short term stress. salivary α-amylase for this study was collected, centrifuged and kept 
frozen until ready to be examined. A Salivette kit was used to collect samples and patients were 
instructed on how to properly use the instrument. The alpha-amylase is measured using a 
quantitative enzymatic kinetic method.  Intra-assay variation is usually less than 7.5% and inter-
assay variability among duplicates less than 6% (Duchemin, 2011). 
Patient Health Questionnaire-9  
The Patient Health Questionnaire (PHQ-9) is used to screen for depressive symptoms and has 
validated cut points for no/minimal, mild, moderate, moderately severe, and severe levels of 
depression.  Respondents report the frequency of bother from depressive symptoms over the past 
two weeks (0 = not at all; 1 = several days; 2 = more than half the days; 3 = nearly every day).  
Scores for individual items are summed for a depressive symptom severity score, which can 
range from 0 (no depression) to 27 (severe depression).  The PHQ-9 has been found to have 
satisfactory sensitivity and specificity for diagnosis of major depressive disorder in diabetic 
patients (Kroenke et al, 2001). Major depressive disorder differs from depressive symptoms in 
terms of symptom severity and length.  For example, a cut-off score of 12 has been 
recommended for diagnosing major depressive disorder and has relatively high specificity in this 
patient population; e.g., sensitivity of 75.7% and a specificity of 80.0%. However, a cut point of 
10 or higher can be appropriate for epidemiological research because it captures a larger group of 
patients with possible depressive disorders (van Steenbergen-Weijenburg et al., 2010). In the 
present study, the PHQ-9 demonstrated moderately high internal consistency reliability (α = .84), 
which is similar to values of .89 and .86 in prior validation research (Kroenke et al., 2001). 
A1c 
Hemoglobin A1c is a point of care test obtained through a capillary finger stick and is used to 
measure longer term glycemic control.  The test indexes the 3-month average of blood glucose 
levels, providing a longer-term indicator of blood glucose control.  The relationship between A1c 
levels and mean plasma glucose levels from data in the international A1c- Derived Average 
Glucose trial found that the correlation between serum glucose and A1c was substantial (r = 
0.92). The ADAG trial found no significant differences between racial and ethnic groups.  
Keeping the A1c level below 7% has shown to reduce the incidence of microvascular and 
possibly macrovascular disease (American Diabetes Association, 2013). 
Diabetes Distress Scale  
Diabetes-related distress refers to the psychological distress associated with the burden of 
diabetes.  The Diabetes Distress Scale (DDS) has four distress-related subscales: emotional 
burden, physician-related distress, regimen-related distress and diabetes-related interpersonal 
distress.  Respondents rate items using a 1 (not a problem) to 6 (serious problem) scale to 
indicate extent of diabetes-related distress.  Polonsky et al. (2005) validated the DDS using four 
diverse sites.  The mean correlation between the total score of the DDS and the four subscales 
was high (r = 0.82).  The DDS had good internal reliability (α > 0.87) and validity across all four 
clinical sites.  Younger subjects had higher DDS scores than older subjects and insulin users 
reported the highest DDS scores.  Total DDS scores was positively associated with depressive 
symptoms, poor adherence to meal planning and little exercise (Polonsky, Fisher, Earles, et al., 
2005). In the present study, the DDS had high internal consistency reliability (α = .92). 
Data Analysis 
SPSS v. 20 statistical analysis software was used to analyze the data. Mean scores, standard 
deviations, and percentages (N %) were used to summarize sociodemographic and clinical 
characteristics of the sample.  A bivariate correlation matrix was used to compare the 
relationships between the unadjusted variables. Multivariate logistic regression analysis was used 
to model the relationships of glycemic control, depression, and stress in predicting the odds of 
CVD risk factors/events, after initially controlling for other socio-demographic characteristics 
and smoking status.  
   
Participant Characteristics (see Table 1) 
 
The participants in this study represented a sociodemographically diverse sample with clinically 
significant psychological distress and cardiovascular risk factors on average.  The sample was 
28.9% male, 42.2% minority, and the mean age was 49.16 years. The average A1c for the sample 
was 8.3% (normal value < 6.5%).  The sample had clinically significant cardiovascular risk 
factors; i.e., 48.8% of the sample reported at least one CVD risk factor or event, 42.2% reported 
hypertension, and 17.8% reported being smokers. The mean PHQ-9 score was 10.67, which 
indicates mild to moderate depressive symptoms on average in the sample.  The DDS mean score 
was 3.07, with a range of scores from 1-6, which indicates a moderately distressed sample in 
relation to diabetes-related sources of distress. The sample had a mean baseline alpha amylase 
values of 76.08 U/ml while an average of 92.4 U/ml has been reported in adults (Salimetrics, 
2012).  However, there was substantial variation in baseline alpha amylase values for this 
sample, ranging from 2.95 to 321.77 U/ml.  
 
  
Bivariate Correlation Matrix (see Table 2) 
     A bivariate correlation matrix was computed to assess the unadjusted relationships between 
each pair of study variables.  Correlations were computed using the parametric Pearson 
correlation (r). The non-parametric equivalent correlations, Kendall’s Tau-B (tau) and the 
Spearman rank order correlation coefficient (rho) were also examined in context of a relatively 
small sample size and non-normal distribution of some study variables.  As shown in the table, 
several unadjusted bivariate correlations were statistically significant. The observed correlations 
are partially consistent with the hypotheses of the association between A1c and smoking status 
with biological and self-report distress measures (PHQ-9, DDS, α-amylase) and cardiovascular 
risk factors/events (heart disease/trouble, hypertension, stroke, kidney disease). Age, gender, and 
A1c were not significantly correlated with cardiovascular risk factors and events.  Smoking 
status was the only significant correlate of cardiovascular risk factors and events. The largest 
correlation of smoking status was with hypertension (r =.309, p < .05), and smoking status was 
also positively associated with A1c as expected (r = .299, p < .05). A1c was associated with 
diabetes-related distress as expected (r = .314, p < .035).  Other relationships between biological 
and self-report measures of distress and CVD risk factors/events were statistically non-
significant in the unadjusted bivariate correlation matrix.   
 
Multivariate Logistic Regression Analysis (see Table 3) 
     After controlling for sociodemographic characteristics (age, race gender), A1c, and smoking 
status (W= 4.632, p=.031), PHQ-9 (W=4.679, p=.031), and DDS (W= 4.345, p=.047) remained 
statistically significant in predicting cardiovascular events and risk factors. When used as a 
continuous variable, salivary α-amylase trended in the direction hypothesized (W= 3.021, 
p=.082), and was likely non-significant in the model due to limited statistical power.  A second 
model using a dichotomized α-amylase score (< 92.4 U/ml; > 92.4 U/ml) based on the reported 
92.4 U/ml average in adults approached statistical significance (p = .051) in predicting CVD risk 
factors/events.  The Nagelkerke R Square for the overall model was .825, showing that 82.5% of 
the results were explained by the model.  The Hosmer and Lemeshow test was .983, showing 
that the model had an excellent overall fit to the data.  
 
Discussion 
     Hypotheses were partially supported in the study model for the associations between DDS, 
PHQ-9, α-amylase and smoking status in the prediction of CVD risk factors and events. For the 
first hypothesis, DDS, PHQ-9 and smoking status remained statistically significant predictors of 
CVD risk factors/events in the full regression model, after adjusting for age, race, gender, and 
A1c.  A dichotomized alpha amylase approached statistical significance in predicting CVD risk 
factors/events, but this result and replication of the other findings would need to be replicated in 
future research with a larger sample size.  For the second hypothesis, in the unadjusted bivariate 
correlation analysis, smoking status and A1c were positively associated as expected, but only 
A1c was associated with diabetes-related distress and only smoking status was positively related 
to self-reported CVD risk factors/events. 
 
     The results of this thesis have implications for refining interventions related to psychological 
health in order to favorably influence the course of T2DM and CVD risk factors and events.  The 
findings replicate prior research on the role of stress, smoking and depression in the development 
of CVD risks and event.  However the findings contribute to new knowledge about the 
relationship between potentially modifiable psychological risk factors and CVD risk factors and 
events. This thesis used both biomarker (α-amylase and A1c) and self-report data (psychological 
distress) variables, and showed that there were statistically reliable relationships between self-
reported distress and biomarkers, as well as ability to predict self-reported CVD risk factors and 
events from both biological and self-report variables.   
 
 Psychological health plays a large role in the progression of both T2DM and cardiovascular 
diseases, and health care interventions should be used by nurses and other types of health care 
providers to modify the risk status of vulnerable patients.  For example, self-reported smoking 
status was a relatively best predictor of self-reported CVD risk factors/events, and underscores 
the central importance of smoking cessation as an intervention that must continue to be offered 
(including provided comprehensive resources needed to support patients to stop smoking).  
Depression screening and similar resources should continue to be part of best practice in settings 
in which patients with T2DM are seen for healthcare services.  This is especially vital as 
inadequately treated depression further exacerbates risk for CVD risk/events and worsens the 
distress of an individual’s diabetes regimen. New patients who self-report CVD risk/events and 
who have T2DM should be prioritized for additional assessment and resources to reduce CVD 
risk factors.  Stress, whether long-term or short-term, can also affect glycemic control and CVD 
risk.  Given the significant impact of stress in T2DM, health care providers must prioritize 
attention and time to explain the importance of stress reduction and to provide needed 
educational and other resources; e.g., education on self-management stress-relieving activities 
such as exercise, yoga and meditation.  Diabetes-related distress is a potentially useful measure 
to inform tailored interventions to reduce distress in T2DM, but is not widely-used by healthcare 
providers to inform care. The DDS or a similar standardized tool to assess diabetes-related 
distress could be usefully incorporated into primary health care for adults with T2DM.  Although 
time constraints often impact counseling time in primary care and other settings for healthcare, 
the results of this thesis underscore the priority importance of taking the time to carefully explain 
self-care management of T2DM to improve A1c levels and reduce CVD risk factors, which in 
turn can significantly reduce the incidence of CVD and CVD-related health events.  
 
Limitations and Future Research 
 
    There are some study limitations that may impact the generalizability.  While statistically 
significant findings were documented that were consistent with a priori hypotheses, a larger 
sample size should be used to potentially replicate findings. Αlpha amylase, while trending 
towards significance, was not statistically significant in the logistic regression models, probably 
due to low statistical power (small sample size) and substantial variability in -amylase values. 
The assay results were reconfirmed by the laboratory that provided the analysis in order to check 
for any technical problems with laboratory procedures and the results were replicated.  However, 
the individual test results could be impacted by a variety of other non-controlled factors, such as 
smoking or a very recent stressful event, aside from longer-term average stress level.  Diabetes-
related distress scores could be impacted by the length of time an individual has had diabetes, 
which would allow more time to adjust to living with diabetes; e.g., a recently- diagnosed 
individual may feel more distress than an individual who has been living with their T2DM 
diagnosis for years.  The Health Conditions Questionnaire is a self-report measure that was used 
to assess CVD risk factors and events, and diagnoses were not confirmed via medical records 
audits.  Therefore it is possible that participants could have either under- or over-reported their 
CVD risk factors and events. Last, the A1c point-of-care test that was used has a maximum 
percentage value of 14% that can be assessed.  Thus it is possible that some participants may 
have had an A1c value over 14%, but the A1c test apparatus would not report the actual value 
beyond 14%.  This could have resulted in truncation of the actual A1c values for some 
participants, reducing the sensitivity of the A1c measure in the reported analyses. 
 
Conclusion 
     This analysis contributes to the theoretical understanding of the relationships between stress, 
depression, diabetes and cardiovascular disease.  The results can lead to more informed health 
care treatment to refine tailored interventions to reduce poor outcomes for patients with CVD 
risk factors and T2DM. Taking care to assess and intervene with modifiable psychological and 
behavioral variables (e.g., stress, depression, smoking, glycemic control) can improve health 
outcomes and quality of life for people who are living with T2DM.  
 
Implications for Nursing Practice 
 
     Nurses are one of the few health care professionals that are with patients at the bedside for the 
majority of the day in acute care settings.  This allows hospital-based nurses the unique 
opportunity to form a rapport with patients to be able to recognize the need for managing 
psychological issues that can complicate T2DM self-management and medical treatment.  The 
results of this thesis research underscore the central importance of intervening with modifiable 
risk factors for which nurses can make a significant difference.  For example, nurses can 
advocate and teach patients who are smokers about smoking cessation treatment and the 
consequences smoking has for the progression of CVD and T2DM.  Nurses can offer basic 
screening tools for depression and diabetes-related distress to improve patient outcomes.  
Patients and nurses alike must recognize the impact and potential consequences of insufficiently 
managed depression, and that even “minor” depression can have a major impact on quality of 
life, ability to manage T2DM, and CVD risk factors and events.  Many people still see 
depression as something that should be dealt with alone or avoid bringing symptoms to the 
attention of healthcare professionals, even when symptoms are clinically significant. Nurses can 
assist with reflecting on the importance of addressing symptoms and relating taking action to 
prevention of adverse health events and improved quality of life. Nurses can also identify 
significant issues and resource needs for hospitalized patients for whom standard discharge 
teaching may not be sufficient to assure follow-through with T2DM management, including 
advocating organizing needed resources and follow-up prior to discharge from the hospital. 
Discharge teaching should go beyond providing information only to including verbal teach back 
of discharge instructions in relation to T2DM, and may usefully even involve a short quiz to 
assess understanding.  This way, issues and misunderstandings with the T2DM management plan 
can be addressed while the patient is still in the inpatient setting, has the resources and staff to 
help improve understanding, and/or the needed resources beyond the patient can be mobilized 
before the patient leaves the hospital.  Primary care providers can also use these approaches at 
outpatient visits to improve patient outcomes.  Patients should be empowered to improve their 
self-management of T2DM via activity and dietary modifications.  Lifestyle changes such as 
improved diet, a workout regimen, weight loss and stress-relieving activities should be 
emphasized just as much as medication adherence during hospital discharge teaching and 
throughout the continuum of care in the community. 
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